The Bispecific Approach, Interviews with Merus, Genmab and NovalGen
Interviewee/Contributor
Bill Lundberg, Tahamtan Ahmadi and Amit Nathwani
Organisation
MedNous
Research Directory
Coronavirus: New treatments in the pipeline
Interviewee/ContributorPeter CharlishOrganisationMedNousWhat we need to know about SARS-CoV-2 variants
Interviewee/ContributorPeter CharlishOrganisationMedNousEU medicine approvals with public health impact
Interviewee/ContributorJane MorrisonOrganisationMedNousDrug development robust, despite the pandemic
Interviewee/ContributorBruno PagliaraOrganisationMedNousTop 10 financing events for ATMPs in 2020
Interviewee/ContributorJane MorrisonOrganisationMedNousLow interest rates, vaccines carry stock values higher
Interviewee/ContributorWilliam EllingtonOrganisationMedNousNew treatments for amyotrophic lateral sclerosis
Interviewee/ContributorPeter CharlishOrganisationMedNousThe role of antibodies in Covid-19 treatment
Interviewee/ContributorPeter CharlishOrganisationMedNousOncology approvals are on an upward trend
Interviewee/ContributorBruno PagliaraOrganisationMedNous